Tech Company Financing Transactions

Curve Biosciences Funding Round

LUMA Capital Partners, Civilization Ventures and First Spark Ventures participated in a $40 million venture round for Curve Biosciences. The round was announced on 10/29/2025.

Transaction Overview

Company Name
Announced On
10/29/2025
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Proceeds Purpose
The funding will advance the clinical validation and commercialization of Curve's Whole-Body Intelligence platform to transform chronic disease monitoring.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Mateo, CA Undisclosed
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Curve Biosciences is the Whole-Body Intelligence company. Curve has created the first molecular blueprint of the human body by manually curating the world's largest collection of comprehensively-characterized tissue samples into its Whole-Body Atlas.
Profile
Curve Biosciences LinkedIn Company Profile
Social Media
Curve Biosciences Company Twitter Account
Company News
Curve Biosciences News
Facebook
Curve Biosciences on Facebook
YouTube
Curve Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ritish Patnaik
  Ritish Patnaik LinkedIn Profile  Ritish Patnaik Twitter Account  Ritish Patnaik News  Ritish Patnaik on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/29/2025: Homecourt venture capital transaction
Next: 10/29/2025: Goddess Maintenance venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary